LadRx Corporation
LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States. The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the tumo… Read more
Market Cap & Net Worth: LadRx Corporation (LADX)
LadRx Corporation (OTCQB:LADX) has a market capitalization of $633.72K ($633.72K) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #42320 globally and #13696 in its home market, demonstrating a -16.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LadRx Corporation's stock price $1.28 by its total outstanding shares 495092 (495.09K).
LadRx Corporation Market Cap History: 2015 to 2025
LadRx Corporation's market capitalization history from 2015 to 2025. Data shows change from $7.87 Million to $633.72K (-23.93% CAGR).
LadRx Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LadRx Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.89x
LadRx Corporation's market cap is 0.89 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $222.79K | $250.00K | -$12.71 Million | 0.89x | N/A |
Competitor Companies of LADX by Market Capitalization
Companies near LadRx Corporation in the global market cap rankings as of March 19, 2026.
Key companies related to LadRx Corporation by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
LadRx Corporation Historical Marketcap From 2015 to 2025
Between 2015 and today, LadRx Corporation's market cap moved from $7.87 Million to $ 633.72K, with a yearly change of -23.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $633.72K | +109.84% |
| 2024 | $302.01K | -53.08% |
| 2023 | $643.62K | +983.33% |
| 2022 | $59.41K | -76.47% |
| 2021 | $252.50K | -70.86% |
| 2020 | $866.41K | +503.45% |
| 2019 | $143.58K | -35.56% |
| 2018 | $222.79K | -73.37% |
| 2017 | $836.71K | -23.87% |
| 2016 | $1.10 Million | -86.04% |
| 2015 | $7.87 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of LadRx Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $633.72K USD |
| MoneyControl | $633.72K USD |
| MarketWatch | $633.72K USD |
| marketcap.company | $633.72K USD |
| Reuters | $633.72K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.